Dec 5, 2022, 10:51 AM by

BRIM Biotechnology, Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that it has raised $20 million in its Series E funding round. This demonstrates the heightened interest and growing demand for new treatments for Dry Eye Disease (DED).

Dec 5, 2022, 10:50 AM by

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, has awarded a $100,000 research grant to Andy Livingston, M.D., a clinician and researcher in Sarcoma Medical Oncology and in Pediatric Oncology at The University of Texas MD Anderson Cancer Center. Ann Graham, Founder and Executive Director of MIB Agents, and Christina Ip-Toma, MIB Agents’ Director of Scientific Programs, presented the award to Dr. Livingston on Dec. 1 in Houston.

Dec 2, 2022, 10:38 AM by

This latest product is an innovative power and data management system that reduces risk and accelerates cleanroom delivery for the life sciences and pharmaceutical industry.

Dec 2, 2022, 10:37 AM by

Dec 2, 2022, 10:36 AM by

Quotient Sciences, a global drug development and manufacturing accelerator, today announced a partnership with Emplicure, a Swedish pharmaceutical company focused on chronic pain and abuse-deterrent formulations.

Dec 2, 2022, 10:33 AM by

Dec 2, 2022, 01:00 AM by User Not Found

Bio-IT World | As digital transformation in the life sciences industry continues, the user experiences (UX) of researchers and scientists interacting with technology and data is coming under closer scrutiny. One area where attention is needed is the role of UX in improving digital accessibility. Better UX for all users will drive innovation, helping to make connections between data and accelerating collaboration.

Dec 1, 2022, 09:49 AM by

The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency How streamlining relations between central labs and mobile health providers can get the most from hybrid and decentralised clinical trials

Dec 1, 2022, 09:47 AM by

The NHS could save up to £360M per year by using FFP3 face masks – the NHS already has a large stockpile of these masks so there is no current need to purchase more. Independent studies commissioned by PPE manufacturer Globus Group and carried out by York Economic Health Consortium and Vital Economics confirm that these masks may be better at preventing respiratory infection and resulting staff days off.

Dec 1, 2022, 09:46 AM by

Dec 1, 2022, 09:34 AM by

Dec 1, 2022, 09:34 AM by

Dec 1, 2022, 09:33 AM by

Dec 1, 2022, 09:26 AM by

VisualDx has teamed up with Emergence Health Holdings, an urgent care network across New England, to grant its providers access to AI-fueled assistive technology to support diagnosis and treatment. Amid concurrent crises, staff shortages, and other challenges in medicine, VisualDx is collaborating with an array of organizations to arm clinicians with tech that helps them do their jobs better, faster, and more accurately. In addition to Emergence, the company also recently teamed up with the Vermont Department of Health, HHS’s Biomedical Advanced Research and Development Authority, and the American College of Emergency Physicians to help clinicians diagnose and treat everything from Covid to Monkeypox, polio, the flu, and more.

Nov 30, 2022, 09:30 AM by

Nov 30, 2022, 09:30 AM by

Nov 30, 2022, 09:30 AM by

Nov 30, 2022, 09:27 AM by

Genezen appoints Jeff Whitmore as Chief Commercial Officer

Nov 30, 2022, 09:27 AM by

Patent-protected Motif data capture interface from uMotif was proven as an equivalent method to capture Patient Reported Outcome and eDiary data, eliminates reliance on text-based instruments, in a study with 55 participants in 2 randomized groups conducted by SAFIRA Clinical Research at Dublin City University.

Nov 30, 2022, 01:00 AM by User Not Found

Bio-IT World | An artificial intelligence-based framework that assesses the effectiveness of novel cancer therapies in real time; three new AI-rare disease partnerships; a cross-border federated network of national genome collections for biomedical research and personalized medicine solutions; multi-scale precision cardiology platforms and heart-on-a-chip technology aimed at developing the infrastructure for a digital replica of an individual’s heart; and more.